Skip to main content
SpringerLink
Log in

Neuronal Dopamine Receptors

  • Chapter
Peripheral Actions of Dopamine

  • 10 Accesses

Abstract

The activity of the sympathetic nervous system can be modulated by a variety of endogenous and exogenous substances which act at specific receptors located either at the postganglionic sympathetic nerve terminals or at the ganglia. Several investigators have reported that varicosities of postganglionic sympathetic nerves contain specific receptors, referred to as presynaptic receptors, activation of which leads to either inhibition or facilitation of NA release during sympathetic nerve stimulation (Lokhandwala, 1979b; Langer, 1980; Lokhandwala and Eikenburg, 1983; Starke, 1987). The presence of a negative feedback presynaptic alpha-adrenoceptor mechanism involved in modulating NA release is now well recognised (Langer, 1980; Starke, 1987). It is reported that NA released from sympathetic nerves activates presynaptic alpha-2-adrenoceptors, inhibits further transmitter release and, hence, controls its own release and subsequently its concentration within the synaptic cleft. Experimental evidence provided in support of this hypothesis is that blockade of presynaptic alpha-2-adrenoceptors and the removal of the endogenous NA on these receptors results in a greater release of the transmitter during sympathetic nerve stimulation and a potentiation of the effector response (Lokhandwala and Buckley, 1976; Langer et al., 1977; Starke, 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ackerman, D. M., Blumberg, A. L., McCafferty, J. P., Sherman, S. S., Weinstock, J., Kaiser, C. and Berkowitz, B. A. (1983). Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526. Fed. Proc., 42, 186–190

    PubMed  CAS  Google Scholar 

  • Adler-Graschinsky, E. and Langer, S. Z. (1975). Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feedback mechanism. Br. J. Pharmac., 54, 43–50

    Article  Google Scholar 

  • Agabiti-Rosei, E., Alicandri, C. L. and Cores, L. (1977). Hypertensive crisis in patients with phaeochromocytomas given metoclopramide. Lancet, i, 600

    Article  Google Scholar 

  • Barrett, R. J. and Lokhandwala, M. F. (1981). Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile. J. Pharmac. Exp. Ther., 217, 660–665

    CAS  Google Scholar 

  • Barrett, R. J. and Lokhandwala, M. F. (1982). Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide. Eur. J. Pharmac., 77, 79–83

    Article  CAS  Google Scholar 

  • Bell, C. (1987). Endogenous renal dopamine and control of blood pressure. Clin. Exp. Hypertension, A9, 955–975

    CAS  Google Scholar 

  • Bogaert, M. G., DeShaepdryver, A. F. and Willems, J. L. (1977). Dopamine-induced neurogenic vasodilation in the intact hindleg of the dog. Br. J. Pharmac., 59, 283–292

    Article  CAS  Google Scholar 

  • Carey, R. M., Thorner, M. O. and Ortt, E. M. (1979). Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. J. Clin. Invest., 63, 727–735

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Carey, R. M., Van Loon, G. R., Baines, A. D. and Kaiser, D. L. (1983). Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocriptine in man. J. Clin. Endocrinol., 56, 585–602

    Article  Google Scholar 

  • Cavero, I., Thiry, C., Pratz, J. and Lawson, K. (1987). Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. Clin. Exp. Hypertension, A9, 931–952

    CAS  Google Scholar 

  • Cole, A. E. and Shinnick-Gallagher, P. (1984). Muscarinic inhibitory transmission in mammalian sympathetic ganglia mediated by increased potassium conductance. Nature, Lond., 307, 270–271

    Article  CAS  Google Scholar 

  • Dinerstein, R. J., Vannice, J., Henderson, R. C., Roth, L. J., Goldberg, L. I. and Hoffmann, P. C (1979). Histofluorescence technique provides evidence for dopamine containing neuronal elements in canine kidney. Science, N.Y., 205, 497–499

    Article  CAS  Google Scholar 

  • Dolmaz, Y., Favre, R., DeHaut, M., Tavitian, E. and Peyrin, L. (1985). The dynamics of dopamine metabolism in the superior cervical, coeliac and mesenteric ganglia. Eur. J. Pharmac., 114, 209–271

    Article  Google Scholar 

  • Dragatakis, L. N., Küchel, O. and Larochelle, P. (1980). Cardiovascular effects of bromocriptine in man. Clin. Pharmac. Ther., 27, 250–251

    Google Scholar 

  • Dubocovich, M. L. and Weiner, N. (1985). Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina. J. Pharmac. Exp. Ther., 233, 747–754

    CAS  Google Scholar 

  • Enero, M. A. and Langer, S. Z. (1975). Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat nictitating membrane. Naunyn-Schmiedebergs Arch. Path. Pharmak., 289, 179–203

    Article  CAS  Google Scholar 

  • Fennell, W. H., Taylor, A. A., Young, J. B., Brandon, T. A., Ginos, J. Z., Goldberg, L. I. and Mitchell, J. R. (1983). Propylbutyldopamine: Hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure. Circulation, 67, 629–636

    Article  Google Scholar 

  • Francis, G. S., Parks, R. and Cohn, J. N. (1983). The effects of bromocriptine in patients with congestive heart failure. Am. Heart J., 106, 100–105

    Article  PubMed  CAS  Google Scholar 

  • Gerber, A., Weidmann, P. and Laederoch, K. (1986). Cardiovascular regulation during administration of co-degocine to normal subjects. Eur. J. Pharmac., 29, 565–572

    Article  CAS  Google Scholar 

  • Gessa, G. L., Mercuro, G. and Rossetti, Z. L. (1986). In Biggio, G., Spano, P. F., Toffano, G. and Gessa, G. L. (Eds.), Modulation of Central and Peripheral Transmitter Function, Fidia Research Series, Symposia in Neuroscience II, Liviana Press, Padua, pp. 203–217

    Google Scholar 

  • Goldberg, L. I. and Kohli, J. D. (1983). Peripheral dopamine receptors: A classification based on potency series and specific antagonism. Trends Pharmac. Sci., 4, 64–66

    Article  CAS  Google Scholar 

  • Greenacre, J. D., Teychenne, P. F., Petrie, A., Calne, D. B., Leigh, P. N. and Reid, J. L. (1976). The cardiovascular effects of bromocriptine in Parkinsonism. Br. J. Clin. Pharmac., 3, 571–576

    Article  CAS  Google Scholar 

  • Grega, G. J., Barrett, R. J., Adamski, S. W. and Lokhandwala, M. F. (1984). Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb. J. Pharmac. Exp. Ther., 229, 756–762

    CAS  Google Scholar 

  • Hilditch, A., Drew, G. M. and Naylor, R. J. (1984). SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors. Eur. J. Pharmac., 97, 333–334

    Article  CAS  Google Scholar 

  • Hope, W., Majewski, H., McCulloch, M. W., Rand, M. J. and Story, D. F. (1979). Modulation of sympathetic neurotransmission by neurally released dopamine. Br. J. Pharmac., 67, 185–192

    Article  CAS  Google Scholar 

  • Hope, W., Majewski, H., McCulloch, M. W., Rand, M. J. and Story, D. F. (1980). Evidence for a modulatory role of dopamine in sympathetic transmission. Circulation Res., 46, Suppl 1, 111–119

    Article  Google Scholar 

  • Horn, P. T., Kohli, J. D. and Goldberg, L. I. (1982). Facilitation of ganglionic transmission by sulpiride: Evidence for an inhibitory role of dopamine in the canine sympathetic ganglion. J. Pharmac. Exp. Ther., 223, 462–468

    CAS  Google Scholar 

  • Inokuchi, K. and Malik, K. U. (1984). Attenuation by prostaglandins of adrenergi-cally induced renal vasoconstriction in anesthetized rats. Am. J. Physiol., 246, R228–R235

    Google Scholar 

  • Johns, W. J., Ayers, C. R. and Carey, R. M. (1984). The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation. J. Cardiovasc. Pharmac., 6, 582–587

    Article  CAS  Google Scholar 

  • Kolloch, R. E., Kobayashi, K. and DeQuattro, V. (1980). Dopaminergic control of sympathetic tone and blood pressure: Evidence in primary hypertension. Hypertension, 2, 330–334

    Article  Google Scholar 

  • Kolloch, R. E., Weidinger, G., Welzel, D. and Stumpe, K. O. (1984). Intravenöse applikation von co-dergocrimmesylot bei hypertensiver Krise: Ein vergleich mit econidin. Herz-Kreise, 16, 417–422

    Google Scholar 

  • Langer, S. Z. (1973). In Usdin, E. and Snyder, S. (Eds.), Frontiers in Catecholamine Research, Pergamon Press, New York, pp. 543–549

    Chapter  Google Scholar 

  • Langer, S. Z. (1980). Presynaptic regulation of the release of catecholamines. Pharmac. Rev., 32, 337–362

    CAS  Google Scholar 

  • Langer, S. Z., Adler-Graschinsky, E. and Giorgi, O. (1977). Physiological significance of the alpha-adrenoceptor mediated negative feedback mechanism that regulates noradrenaline release during nerve stimulation. Nature, Lond., 265, 648–650

    Article  CAS  Google Scholar 

  • Lewis, M. J. and Henderson, A. H. (1980). The effects of bromocriptine in methyl-dopa-treated hypertension. Br. J. Clin. Pharmac., 8, 57–60

    Article  Google Scholar 

  • Libet, B. (1970). Generation of slow inhibitory and excitatory postsynaptic potentials. Fed. Proc., 29, 1945–1956

    PubMed  CAS  Google Scholar 

  • Libet, B. and Tosaka, T. (1969) Slow inhibitory and excitatory postsynaptic responses in single cells of mammalian sympathetic ganglia. J. Neurophysiol., 32, 43–50

    PubMed  CAS  Google Scholar 

  • Linch, D. C., Shaw, K. M., Muhlemann, M. F. and Ross, E. J. (1978). Bromocriptine-induced postural hypotension in acromegaly. Lancet, ii, 320–321

    Article  Google Scholar 

  • Loffelholz, K. and Muscholl, E. (1969). A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedebergs Arch. Path. Pharmak., 265, 1–15

    Article  CAS  Google Scholar 

  • Lokhandwala, M. F. (1978). Inhibition of sympathetic nervous system by histamine: Studies with H1 and H2-receptor antagonists. J. Pharmac. Exp. Ther., 206, 115–122

    CAS  Google Scholar 

  • Lokhandwala, M. F. (1979a). Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function. Eur. J. Pharmac., 56, 253–256

    Article  CAS  Google Scholar 

  • Lokhandwala, M. F. (1979b). Presynaptic receptor systems on cardiac sympathetic nerves. Life Sci., 24, 1823–1832

    Article  PubMed  CAS  Google Scholar 

  • Lokhandwala, M. F., Amelang, E. and Buckley, J. P. (1978). Facilitation of cardiac sympathetic function by angiotensin. II: Role of presynaptic angiotensin receptors. Eur. J. Pharmac., 52, 405–409

    Article  CAS  Google Scholar 

  • Lokhandwala, M. F. and Barrett, R. J. (1982). Cardiovascular dopamine receptors: Physiological, pharmacological and therapeutic implications. J. Autonom. Pharmac., 3, 189–215

    Article  Google Scholar 

  • Lokhandwala, M. F. and Buckley, J. P. (1976). Effect of presynaptic alpha-adrenoceptor blockade on responses to cardiac nerve stimulation on anesthetized dogs. Eur. J. Pharmac., 40, 183–186

    Article  CAS  Google Scholar 

  • Lokhandwala, M. F. and Buckley, J. P. (1977a). Analysis of presynaptic inhibitory actions of various dopamine analogs on sympathetic neurotransmission in mongrel dogs. Life Sci., 20, 507–516

    Article  PubMed  CAS  Google Scholar 

  • Lokhandwala, M. F. and Buckley, J. P. (1977b). Presynaptic dopamine receptors as mediators of dopamine-induced inhibition of neurogenic vasoconstriction. Eur. J. Pharmac., 45, 305–309

    Article  CAS  Google Scholar 

  • Lokhandwala, M. F., DeFeo, M. L. and Cavero, I. (1987a). In Saito, H. (Ed.), Progress in Hypertension, Vol. 1, Neurotransmitters as Modulators of Blood Pressure, V.N.U. Int. Science Press, Holland, pp. 115–144

    Google Scholar 

  • Lokhandwala, M. F. and Eikenburg, D. C. (1983). Presynaptic receptors and alterations in norepinephrine release in spontaneously hypertensive rats. Life Sci., 33, 1527–1542

    Article  PubMed  CAS  Google Scholar 

  • Lokhandwala, M. F. and Martinez, A. M. (1980). Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine on sympathetic neurotransmission to the myocardium. Eur. J. Pharmac., 63, 303–311

    Article  Google Scholar 

  • Lokhandwala, M. F. and Sabouni, M. H. (1985). Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam. J. Autonom. Pharmac., 5, 301–305

    Article  CAS  Google Scholar 

  • Lokhandwala, M. F. and Steenberg, M. L. (1984a). Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and the influence of stimulation parameters in the action of dopamine. J. Pharmac. Exp. Ther., 228, 161–167

    CAS  Google Scholar 

  • Lokhandwala, M. F. and Steenberg, M. L. (1984b). Evaluation of the effects of SKF 82526 and LY171555 on presynaptic and postsynaptic dopamine receptors in the rat kidney. J. Autonom. Pharmac., 4, 173–177

    Article  Google Scholar 

  • Lokhandwala, M. F., Tadepalli, A. S. and Jandhyala, B. S. (1979). Cardiovascular actions of bromocriptine: Evidence for a neurogenic mechanism. J. Pharmac. Exp. Ther., 211, 620–625

    CAS  Google Scholar 

  • Lokhandwala, M. F., Watkins, H. O. and Dlewati, A. (1987b). Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK&F 85174 in the dog hindlimb. Eur. J. Pharmac., 143, 383–390

    Article  CAS  Google Scholar 

  • Lokhandwala, M. F., Watkins, H. O., Sabouni, M. H. and Alkadhi, K. A. (1985). Pharmacological analysis of the action of SKF 82526 on cardiovascular dopamine receptors. J. Pharmac. Exp. Ther., 234, 337–343

    CAS  Google Scholar 

  • McAfee, D. A. and Greengard, P. (1972). Adenosine 3′,5′-monophosphate: Electrophysiological evidence for a role in synaptic transmission. Science, N. Y., 178, 310–312

    Article  CAS  Google Scholar 

  • Mannelli, M., DeFeo, M. L., Maggi, M., Salvetti, A., Giusti, G. and Serio, M. (1985). Does endogenous dopamine modulate human sympathetic activity through DA-2 receptors? Eur. J. Clin. Pharmac., 23, 155–164

    Google Scholar 

  • Mannelli, M. Delitala, F., DeFeo, M. L., Maggi, M., Cuomo, S., Piazzini, M., Guazzelli, R. and Serio, M. (1984). Effect of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. J. Clin. Endocrinol. Metab., 59, 74–78

    Article  PubMed  CAS  Google Scholar 

  • Mercuro, G., Rossetti, Z. L., Rivano, C. A., Ruscazio, M., Tocco, L., Gessa, G. L. and Cherchi, A. (1987). Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans. Hypertension, 9, 35–40

    Article  PubMed  CAS  Google Scholar 

  • Mercuro, F., Rossetti, Z. L., Tocco, L., Rivano, C. A., Cherchi, A. and Gessa, G. L. (1985). Bromocriptine reduces plasma noradrenaline and 3,4-dihydrophenylacetic acid in normal and hypertensive subjects. Eur. J. Clin. Pharmac., 27, 671–675

    Article  CAS  Google Scholar 

  • Mohanty, P. K., Sowers, J. K., Beck, F. W. J., Godscholk, M. F., Schmitt, J., Newton, M., McNamara, C., Verbalis, J. G. and McClanahan, M. (1985). Catecholamine, renin, aldosterone and arginine-vasopressin responses to tilt in normal humans: Effects to bromocriptine. J. Cardiovasc. Pharmac., 7, 1040–1047

    Article  CAS  Google Scholar 

  • Montastruc, J. L., Chamontin, B., Lenord, J. M. and Rascol, A. (1985). Domperidone in the management of orthostatic hypotension. Clin. Neuropharmac., 8, 131–132

    Article  Google Scholar 

  • Montastruc, J. L., Chamontin, B., Rostin, M., Rascol, M., Valet, P. H., Gillard, G., Tran, M. A., Tran Van, T., Adler, J. L. and Montastruc, P. (1987). Experimental and clinical approaches to treatment of hypertension by dopamine receptor agonists. Clin. Exp. Hypertension, A9, 1069–1084

    CAS  Google Scholar 

  • Neff, N. H., Karoum, F. and Hadjiconstantinou, M. M. (1983). Dopamine-containing small intensely fluorescent cells and sympathetic ganglion function. Fed. Proc., 42, 3009–3011

    PubMed  CAS  Google Scholar 

  • Plovin, P. F., Menord, J., Corvol, P. (1976). Hypertensive crisis in patients with phaeochromocytoma given metoclopramide. Lancet, ii, 1357–1358

    Google Scholar 

  • Quenzer, L., Yahn, D., Alkadhi, K. and Voile, R. L. (1979). Transmission blockade and stimulation of ganglionic adenylate cyclase by catecholamines. J. Pharmac. Exp. Ther., 208, 31–36

    CAS  Google Scholar 

  • Rascol, O. J. and Montastruc, J. L. (1987). Cardiovascular effects of apomorphine in man: Evidence for peripheral mechanisms. Clin. Neuropharmac. (in press)

    Google Scholar 

  • Sabouni, M. H., Alkadhi, K. A. and Lokhandwala, M. F. (1986). Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA-1 and DA-2 receptor agonists and antagonists. J. Pharmac. Exp. Ther., 238, 541–543

    Google Scholar 

  • Sabouni, M. H., Alkadhi, K. A. and Lokhandwala, M. F. (1987). Effect of dopamine receptor activation on ganglionic transmission and cyclic-AMP levels in the stellate ganglia and renal arteries of the dog. J. Pharmac. Exp. Ther., 240, 93–98

    CAS  Google Scholar 

  • Sengupta, S. and Lokhandwala, M. F. (1985). Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anesthetized rats. J. Autonom. Pharmac., 5, 289–293

    Article  CAS  Google Scholar 

  • Soares-da-Silva, P. (1987). Dopamine released from nerve terminals activates prejunctional dopamine receptors in dog mesenteric arterial vessels. Br. J. Pharmac., 91, 591–599

    Article  CAS  Google Scholar 

  • Sowers, J. R., Golub, M. S., Berger, M. E. and Whitefield, L. A. (1982a). Dopaminergic modulation of pressor and hormonal responses in essential hypertension. Hypertension, 4, 424–430

    Article  PubMed  CAS  Google Scholar 

  • Sowers, J. R., Stern, N., Nyby, M. D. and Jasberg, K. A. (1982b). Dopaminergic regulations of circadian rhythms, blood pressure, renin and aldosterone in essential hypertension. Cardiovasc Res., 16, 317–323

    Article  PubMed  CAS  Google Scholar 

  • Starke, K. (1987). Presynaptic α-autoreceptors. Rev. Physiol. Biochem. Pharmac., 107, 73–146

    CAS  Google Scholar 

  • Steardo, L., DiStasio, E., Boruso, S. and Maj, M. (1986). The effect of bromocriptine on plasma catecholamine concentrations in normal volunteers. Eur. J. Clin. Pharmac., 23, 713–715

    Article  Google Scholar 

  • Stumpe, K. O., Higuchi, M., Kolloch, R., Kruck, F. and Vetter, H. (1977). Hyper-prolectinomia and antihypertensive effect of bromocriptine in essential hypertension: Identification of abnormal central dopamine control. Lancet, ii, 211–214

    Article  Google Scholar 

  • Szabo, B., Hedler, L., Ensinger, H. and Starke, K. (1986). Opioid peptides decrease noradrenaline release and blood pressure in the rabbit at peripheral receptors. Naunyn-Schmiedebergs Arch. Path. Pharmak., 332, 50–56

    Article  CAS  Google Scholar 

  • Taylor, A. A., Fennell, W. H., Ruud, C. O., Pool, J. L., Nelson, E. B., Ginos, J. Z. and Mitchell, J. R. (1984). Propylbutyldopamine: Mechanisms of blood pressure lowering in hypertensive patients. Hypertension, 6 (Suppl. 1), 40–45

    Article  Google Scholar 

  • Teychenne, P. F., Calne, D. B., Leigh, P. N., Greenacre, J. K., Reid, J. L., Petrie, A. and Bamji, A. N. (1975). Idiopathic Parkinsonism treated with bromocriptine. Lancet, ii, 473–476

    Article  Google Scholar 

  • Thorner, M. O., Chait, A., Aitken, M., Benker, G., Bloom, S. R., Mortimer, C. H., Sanders, P., Stuart Mason, A. and Besser, G. M. (1975). Bromocriptine treatment of acromegaly. Br. Med. J., 7, 288–303

    Google Scholar 

  • Van Loon, G. R., Sole, M. J., Bain, J. and Rose, J. L. (1978). Effects of bromocriptine on plasma catecholamines in normal man. Neuroendocrinology, 28, 4325–4434

    Google Scholar 

  • Waiden, R. J., Hernandez, J., Bhattacharjee, P., Graham, B. and Prichard, B. N. C. (1986). Bromocriptine in the treatment of hypertension. Eur. J. Clin. Pharmac., 30, 141–144

    Article  Google Scholar 

  • Weth, G. (1984). Clinical, endocrinological and biochemical effects of co-dergocrine mesylate in antihypertensive crisis in aged patients. Eur. Heart J., 5, (Suppl. 1), 333

    Google Scholar 

  • Whitfield, L., Sowers, J. R., Tuck, M. L. and Golub, M. S. (1980). Dopaminergic control of plasma catecholamines and aldosterone responses to acute stimuli in normal man. J. Clin. Endocrinol. Metab., 51, 724–729

    Article  PubMed  CAS  Google Scholar 

  • Wilffert, B., Davidesko, D., DeJonge, A., Thoolen, M. J. M. C., Timmermans, P. B. M. W. M. and VanZwieten, P. A. (1983). Role of ganglionic M-1 and M-2 receptors in the neuronal control of the cardiovascular system of the normotensive rat as determined with pilocarpine. Eur. J. Pharmac., 95, 109–116

    Article  CAS  Google Scholar 

  • Willems, J. L., Buylaert, W. A., Lefebvre, R. A. and Bogaert, M. G. (1985). Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmac. Rev., 37, 165–216

    CAS  Google Scholar 

  • Wilson, T. A., Kaiser, D. L. and Carey, R. M. (1983). Dopaminergic inhibition of aldosterone secretion is independent of the autonomic nervous system. J. Clin. Endocrinol. Metab., 57, 200–203

    Article  PubMed  CAS  Google Scholar 

  • Ziegler, M. G., Lake, C. R., Williams, A. C., Teychenne, P. F., Shoulson, I. and Steinsland, O. (1979). Bromocriptine inhibits norepinephrine release. Clin. Pharmac. Ther., 25, 137–142

    Article  CAS  Google Scholar 

Download references

Authors
  1. Mustafa F. Lokhandwala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Laura DeFeo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physiology, University of Melbourne Medical Centre, Australia

    Christopher Bell

  2. Department of Medicine, Monash University Medical Centre, Australia

    Barry McGrath

Copyright information

© 1988 Mustafa F. Lokhandwala and Maria Laura DeFeo

About this chapter

Cite this chapter

Lokhandwala, M.F., DeFeo, M.L. (1988). Neuronal Dopamine Receptors. In: Bell, C., McGrath, B. (eds) Peripheral Actions of Dopamine. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave, London. https://doi.org/10.1007/978-1-349-09503-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-09503-2_10

  • Publisher Name: Palgrave, London

  • Print ISBN: 978-1-349-09505-6

  • Online ISBN: 978-1-349-09503-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation